Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
- PMID: 29128916
- PMCID: PMC5823507
- DOI: 10.1007/s11892-017-0956-2
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Abstract
Purpose of review: Polycystic ovary syndrome (PCOS) is diagnosed by its characteristic reproductive features. However, PCOS is also associated with metabolic abnormalities, including insulin resistance and β-cell dysfunction. The severity of these abnormalities varies according to the reproductive phenotype, with the so-called NIH or classic phenotype conferring the greatest metabolic risk. The increased risk for type 2 diabetes (T2D) is well established among affected women with the NIH phenotype, but whether PCOS also confers an increased risk for cardiovascular events remains unknown.
Recent findings: Recent studies in daughters of affected women have found evidence for pancreatic β-cell dysfunction prior to menarche. Further, genetic analyses have provided evidence that metabolic abnormalities such as obesity and insulin resistance contribute to the pathogenesis of PCOS. PCOS increases the risk for T2D. However, the risk for cardiovascular disease has not been quantified, and prospective, longitudinal studies are still critically needed.
Keywords: Cardiovascular disease; Insulin resistance; Obesity; Polycystic ovary syndrome; Type 2 diabetes.
Figures

Similar articles
-
Cardiometabolic risks in PCOS: a review of the current state of knowledge.Expert Rev Endocrinol Metab. 2019 Jan;14(1):23-33. doi: 10.1080/17446651.2019.1556094. Epub 2018 Dec 15. Expert Rev Endocrinol Metab. 2019. PMID: 30556433 Review.
-
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.Hum Reprod Update. 2009 Jul-Aug;15(4):477-88. doi: 10.1093/humupd/dmp008. Epub 2009 Mar 11. Hum Reprod Update. 2009. PMID: 19279045 Review.
-
Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.Nutr Res Rev. 2017 Jun;30(1):97-105. doi: 10.1017/S0954422416000287. Epub 2017 Feb 22. Nutr Res Rev. 2017. PMID: 28222828 Review.
-
Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.Arq Bras Endocrinol Metabol. 2014 Mar;58(2):182-7. doi: 10.1590/0004-2730000003051. Arq Bras Endocrinol Metabol. 2014. PMID: 24830595 Review.
-
Polycystic ovary syndrome, adipose tissue and metabolic syndrome.Arch Gynecol Obstet. 2017 Sep;296(3):405-419. doi: 10.1007/s00404-017-4429-2. Epub 2017 Jun 22. Arch Gynecol Obstet. 2017. PMID: 28643028 Review.
Cited by
-
From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management.Int J Endocrinol. 2020 Jun 8;2020:6276187. doi: 10.1155/2020/6276187. eCollection 2020. Int J Endocrinol. 2020. PMID: 32587614 Free PMC article. Review.
-
Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?Endocr Connect. 2022 Apr 22;11(4):e210358. doi: 10.1530/EC-21-0358. Endocr Connect. 2022. PMID: 35258478 Free PMC article.
-
Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome.PLoS One. 2021 Apr 2;16(4):e0249639. doi: 10.1371/journal.pone.0249639. eCollection 2021. PLoS One. 2021. PMID: 33798258 Free PMC article.
-
Acupuncture in Women with Human Polycystic Ovary/Ovarian Syndrome: Protocol for a Randomized Controlled Trial.Healthcare (Basel). 2022 Oct 11;10(10):1999. doi: 10.3390/healthcare10101999. Healthcare (Basel). 2022. PMID: 36292446 Free PMC article.
-
The Effect and Safety Assessment of Metformin and DLBS3233 (A Bioactive Fraction of Lagerstroemia speciosa and Cinnamomum burmannii) on Improving Metabolic Parameters in Women with Polycystic Ovary Syndrome.Int J Womens Health. 2023 Jul 4;15:971-985. doi: 10.2147/IJWH.S409685. eCollection 2023. Int J Womens Health. 2023. PMID: 37424700 Free PMC article.
References
-
- Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165–74. - PubMed
-
- Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006;91(2):492–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials